<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>CMV_J</title>
    <meta name="title" content="NHANES 2017-2018: Cytomegalovirus IgG &amp; IgM Antibodies - Serum Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXIGG">LBXIGG - Cytomegalovirus (CMV) IgG</a>
              </li>
              <li>
                <a href="#LBXIGM">LBXIGM - Cytomegalovirus (CMV) IgM</a>
              </li>
              <li>
                <a href="#LBXIGGA">LBXIGGA - Cytomegalovirus (CMV) IgG avidity</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2017-2018 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Cytomegalovirus IgG &amp; IgM Antibodies - Serum (CMV_J)</h3>
        <h4> Data File: CMV_J.xpt</h4>
        <h5 class="left">First Published: February 2020</h5>
        <h5 class="right">Last Revised: June 2020</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p>Cytomegalovirus (CMV) is a herpesvirus, which can be a
serious pathogen in infants and adults.&nbsp; CMV
usually does not cause significant disease in healthy individuals, but pregnant
women can transmit CMV to their unborn babies, who are then at risk. Congenital
CMV infection is a significant source of morbidity among children, causing a
wide range of clinical outcomes including jaundice, hydrocephalia, hearing loss,
ocular lesions, and even death. Currently, about one out of every 200 babies are
born with congenital CMV infection each year. </p>
<p>In the United States, one in three children are already
infected with CMV by age five. Young children with CMV infection shed the virus
in high titers and are a major source of transmission to other susceptible
children and adults, which is of special concern for pregnant women. For this
reason, characterizing infection among children less than 6 years old is
essential to expanding our understanding of important transmission exposures,
mainly breastfeeding and close contact during childcare, and patterns of
primary and recurrent infections. Such information would inform the development
of prevention strategies to protect vulnerable populations, including pregnant
women and their fetuses.</p>
<p>Additionally, young children have been identified as a
potential target population for CMV vaccine development, recently ranked of highest
priority by the Institute of Medicine. Describing the serological profile of
children under the age of 6 would improve our understanding of immunity during
early childhood and facilitate vaccine development. </p><h2 id="Eligible_Sample">Eligible Sample</h2><p>Examined participants aged 1 to 5 years were eligible.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p>CMV Immunoglobulin G (IgG) antibodies are detected by enzyme-linked
fluorescent immunoassay (ELFA) in a semiquantitative-automated manner, using
the VIDAS CMV method designed by Biomerieux. All NHANES specimen numbers were
scanned by the barcode reader. The VIDAS instrument reads the specimen
reactivity of each sample and assigns numeric values. </p>
<p>Refer to the laboratory method files section for a
detailed description of the laboratory method files used.</p>
<p>CMV cycled back into the survey from NHANES 2011-2012 and
there were no changes to the lab method, lab equipment, or lab site for this
component in the NHANES 2017-2018 cycle.&nbsp;
</p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2017/labmethods/CMV-J-MET-508.pdf">Cytomegalovirus (CMV) serology (IgG, IgM, and avidity)</a>
          <span> (February 2020)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p>Serum specimens were processed, stored, and shipped to
the National Center for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, GA for analysis.&nbsp; </p>
<p>Detailed instructions on specimen collection and
processing instructions are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf" target="_blank">NHANES Laboratory Procedures Manual (LPM).&nbsp; </a>Vials were stored under appropriate frozen
(-30<sup>o</sup>C) conditions until they were shipped to the National Center
for Infectious Diseases for testing.</p>
<p>The NHANES quality assurance and quality control (QA/QC)
protocols meet the 1988 Clinical Laboratory Improvement Amendments mandates. Detailed QA/QC
instructions are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf" target="_blank">NHANES LPM</a>. </p>
<p><b>Mobile Examination Centers (MECs)</b></p>
<p>Laboratory team performance is monitored using several
techniques. NCHS and contract consultants use a structured competency
assessment evaluation during visits to evaluate both the quality of the
laboratory work and the quality-control procedures. Each laboratory staff member
is observed for equipment operation, specimen collection and preparation;
testing procedures and constructive feedback are given to each staff member.
Formal retraining sessions are conducted annually to ensure that required skill
levels were maintained.</p>
<p><b>Analytical Laboratories</b></p>
<p>NHANES uses several methods to monitor the quality of the
analyses performed by the contract laboratories. In the MEC, these methods
include performing blind split samples collected during &ldquo;dry run&rdquo; sessions. In
addition, contract laboratories randomly perform repeat testing on 2% of all
specimens.</p>
<p>NCHS developed and distributed a QC protocol for all CDC and
contract laboratories, which outlined the use of Westgard rules (Westgard, et al.
1981)
when running NHANES specimens. Progress reports containing any problems
encountered during shipping or receipt of specimens, summary statistics for
each control pool, QC graphs, instrument calibration, reagents, and any special
considerations are submitted to NCHS quarterly. The reports are reviewed for
trends or shifts in the data. The laboratories are required to explain any
identified areas of concern.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p>The data were reviewed.&nbsp;
Incomplete data and improbable values were sent to the performing laboratory
for confirmation.&nbsp; </p><h2 id="Analytic_Notes">Analytic Notes</h2><p>Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2017" target="_blank">2017-2018 Laboratory Data Overview </a>for general information on NHANES laboratory data.</p>
<p>There are over 800 laboratory tests performed on NHANES participants. However, not all participants provided biospecimens or enough volume for all the tests to be performed. The specimen availability can also vary by age or other population characteristics. For example, in 2017-2018, approximately 80% of children aged 1-17 years who were examined in the MEC provided a blood specimen through phlebotomy, while 95% of examined adults age 18 and older provided a blood specimen. Analysts should evaluate the extent of missing data in the dataset related to the outcome of interest as well as any predictor variables used in the analyses to determine whether additional re-weighting for item non-response is necessary.&nbsp;</p>
<p>Please refer to the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx" target="_blank">Analytic Guidelines </a>and
the on-line NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx" target="_blank">Tutorial</a> for details on the
use of sample weights and analytic issues.</p>
<p><b>Demographic and Other Related Variables</b></p>
<p>The analysis of NHANES laboratory data must be conducted
using the appropriate survey design and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2017" target="_blank">NHANES
2017-2018 Demographics File </a>contains demographic data, health
indicators, and other related information collected during household interviews
as well as the sample design variables. The recommended procedure for variance
estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU,
respectively) in the demographic data file.</p>
<p>This laboratory data file can be linked to the other NHANES
data files using the unique survey participant identifier (i.e., SEQN).</p>
<p><b>Detection Limits</b></p>
<p>Since this data is reported as qualitative data, the use of
lower limit of detections (LLODs) isn&rsquo;t applicable. </p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 27:493-501.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXIGG">LBXIGG - Cytomegalovirus (CMV) IgG</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXIGG</dd>
            <dt>SAS Label: </dt>
            <dd>Cytomegalovirus (CMV) IgG</dd>
            <dt>English Text: </dt>
            <dd class="info">Cytomegalovirus (CMV) IgG</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">positive</td>
                <td class="values" align="right">168</td>
                <td class="values" align="right">168</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">negative</td>
                <td class="values" align="right">438</td>
                <td class="values" align="right">606</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">indeterminate</td>
                <td class="values" align="right">1</td>
                <td class="values" align="right">607</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">324</td>
                <td class="values" align="right">931</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXIGM">LBXIGM - Cytomegalovirus (CMV) IgM</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXIGM</dd>
            <dt>SAS Label: </dt>
            <dd>Cytomegalovirus (CMV) IgM</dd>
            <dt>English Text: </dt>
            <dd class="info">Cytomegalovirus (CMV) IgM</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">positive</td>
                <td class="values" align="right">3</td>
                <td class="values" align="right">3</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">negative</td>
                <td class="values" align="right">600</td>
                <td class="values" align="right">603</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">indeterminate</td>
                <td class="values" align="right">4</td>
                <td class="values" align="right">607</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">324</td>
                <td class="values" align="right">931</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXIGGA">LBXIGGA - Cytomegalovirus (CMV) IgG avidity</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXIGGA</dd>
            <dt>SAS Label: </dt>
            <dd>Cytomegalovirus (CMV) IgG avidity</dd>
            <dt>English Text: </dt>
            <dd class="info">Cytomegalovirus (CMV) IgG avidity</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">low</td>
                <td class="values" align="right">16</td>
                <td class="values" align="right">16</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">high</td>
                <td class="values" align="right">146</td>
                <td class="values" align="right">162</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">indeterminate</td>
                <td class="values" align="right">6</td>
                <td class="values" align="right">168</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">763</td>
                <td class="values" align="right">931</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>